Assyro AI

Orange Book product · Generic (ANDA)

ACYCLOVIR

ACYCLOVIR

Generic (ANDA)ANDA 215669TE ABRX HETERO LABS LTD III
View ACYCLOVIR familyOpen on FDA Orange Book

At a glance

Jul 01, 2022

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 01, 2022

    4 yr ago

  2. Today

Pharmaceutical detail

Active ingredient

ACYCLOVIR

Strength

200MG/5ML

Dosage form

SUSPENSION

Route

ORAL

TE code

AB

Application

ANDA 215669

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ACYCLOVIR

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo